PDCD1 and neoplasm: We observed that the effect on the tumor growth of OX40L/PPT alone, anti-PD-1 alone or their combination did not differ between the three groups, though it was obviously pronounced compared to control groups (control systemic antibody, IgG2a, and intact control), Figure 4.